Contracts Finder · Tender
NHS National Generic Pharmaceuticals - Lenalidomide
A public procurement published by NHS England via Contracts Finder.
- —
- Award value
- £70m
- Tender value
- 0
- Suppliers
- 0
- Awards
- 1
- Notices
- Tender
- Stage
Overview
Find a Tender (FTS) Reference number: 2022/S 000-017584 Invitation to offer for NHS National Generic Pharmaceuticals - Lenalidomide Offer reference number: CM/PHG/21/5638 Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Lenalidomide: ALL REGIONS: 01/09/2022 to 31/08/2023 (12 months)
Key details
- Buyer
- NHS England
- Source
- Contracts Finder
- Lifecycle stage
- Tender
- Status
- active
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- —
- Tender value
- £70,000,000
- First published
- 28 Jun 2022
- Last updated
- 28 Jun 2022
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from NHS England
FAQs about this procurement
Who is the buyer for "NHS National Generic Pharmaceuticals - Lenalidomide"?
NHS National Generic Pharmaceuticals - Lenalidomide is a UK public-sector procurement published by NHS England via Contracts Finder.
Has "NHS National Generic Pharmaceuticals - Lenalidomide" been awarded?
No award has been recorded yet. The current lifecycle stage is "Tender".
What is "NHS National Generic Pharmaceuticals - Lenalidomide" worth?
The reported tender value is £70,000,000.
When was "NHS National Generic Pharmaceuticals - Lenalidomide" published?
It was first published on 28 Jun 2022 and last updated on 28 Jun 2022, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable